Dougherty & Co Downgrades Myriad Genetics (MYGN) to Neutral; 2013 Reimbursement Uncertainty
Go back to Dougherty & Co Downgrades Myriad Genetics (MYGN) to Neutral; 2013 Reimbursement Uncertainty| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.19 +0.32 (11.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.87 | 52 Week High | $45.34 | |||
| Open | $2.95 | 52 Week Low | $15.92 | |||
| Day High | $3.20 | P/E | 1.37 | |||
| Day Low | $2.92 | EPS | $2.33 | |||
| Volume | 2,194,149 | |||||
